Brink's (BCO) Q1 2026 Earnings Transcript

Brink's reported Q1 revenue up 10% with 4.5% organic growth and 10bps margin expansion, while adjusted EBITDA rose 10% to $238 million and free cash flow reached $502 million trailing 12 months, up to 50% conversion. AMS/DRS organic growth remained strong at 15% for the 13th straight quarter, and management guided Q2 revenue to $1.37B-$1.43B with EPS of $1.85-$2.25 and continued mid-single-digit organic growth for 2026. The NCR Atleos deal remains on track, with $200 million of anticipated synergies and leverage expected to fall to 2.3x by year-end.

Analysis

BCO is now behaving less like a legacy armored-car operator and more like a high-margin, recurring-revenue compounder, and that matters for multiple holds on the cap table. The second-order effect is that every incremental AMS/DRS win dilutes the economics of the old CVM franchise while expanding customer stickiness; that usually precedes a valuation regime shift before the income statement fully catches up. The market is likely still underestimating how much the mix shift plus network density can compress the gap between BCO and traditional route-based service companies.

The cleaner read is that this is not just growth, it is financing optionality. Lower debt cost on the acquired balance sheet plus improving working capital turns free cash flow into an acquisition-defense flywheel: more cash generation supports de-levering now, while integration synergies can later be redeployed into buybacks or tuck-ins. The key risk is execution slippage around a 2027 close; any regulatory delay, customer churn during integration, or failure to realize density benefits would push the equity back toward a “good operator, expensive story” multiple.

The most interesting contrarian angle is that consensus may be too focused on the headline M&A and not enough on organic duration. Mid-to-high teens recurring revenue growth with two-thirds of installs from net-new customers suggests the TAM is broader than the sell-side model likely assumes, especially in underpenetrated emerging markets and North America DRS. If that pace holds through the second half, the stock can rerate before deal close; if it slows, the re-rating argument breaks quickly because the current narrative is carrying a lot of the multiple.

Key Decisions for Investors

• Go long BCO into the next 1-2 quarters on any post-earnings consolidation; use a 3-6 month horizon targeting a rerating as recurring revenue mix expands. Risk/reward is attractive as long as AMS/DRS stays in the mid-teens and leverage trends toward 2.3x.
• Pair trade: long BCO / short a basket of legacy cash-handling or route-density names over 3-6 months. The thesis is that BCO’s mix shift and cash conversion inflect faster than peers exposed to pure volume or fuel-sensitive legacy logistics.
• Add BCO on pullbacks rather than breakouts; the cleaner entry is any drawdown tied to M&A noise or macro FX headlines, not operational weakness. Use a stop if organic AMS/DRS growth falls below low-teens for two consecutive quarters.
• For event-driven accounts, consider a call spread in BCO that spans the 2027 deal window. This captures rerating from execution and synergies while limiting downside if regulatory timing slips.
• Avoid chasing the stock if it gaps higher on deal optimism alone; wait for confirmation that free cash flow conversion remains near or above the 40%-45% range, since that is the metric most likely to force upward estimate revisions.